These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 20133450)

  • 1. Haemodilution-induced profibrinolytic state is mitigated by fresh-frozen plasma: implications for early haemostatic intervention in massive haemorrhage.
    Bolliger D; Szlam F; Levy JH; Molinaro RJ; Tanaka KA
    Br J Anaesth; 2010 Mar; 104(3):318-25. PubMed ID: 20133450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Finding the optimal concentration range for fibrinogen replacement after severe haemodilution: an in vitro model.
    Bolliger D; Szlam F; Molinaro RJ; Rahe-Meyer N; Levy JH; Tanaka KA
    Br J Anaesth; 2009 Jun; 102(6):793-9. PubMed ID: 19420005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The in-vitro effect of fibrinogen, factor XIII and thrombin-activatable fibrinolysis inhibitor on clot formation and susceptibility to tissue plasminogen activator-induced fibrinolysis in hemodilution model.
    Shenkman B; Livnat T; Lubetsky A; Tamarin I; Budnik I; Einav Y; Martinowitz U
    Blood Coagul Fibrinolysis; 2012 Jul; 23(5):370-8. PubMed ID: 22498982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibrinogen concentrate and cryoprecipitate but not fresh frozen plasma correct low fibrinogen concentrations following in vitro haemodilution.
    Fenger-Eriksen C; Christiansen K; Laurie J; Sørensen B; Rea C
    Thromb Res; 2013 May; 131(5):e210-3. PubMed ID: 23473642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of recombinant activated factor VII on thrombin-mediated feedback activation of coagulation.
    Taketomi T; Szlam F; Bader SO; Sheppard CA; Levy JH; Tanaka KA
    Blood Coagul Fibrinolysis; 2008 Mar; 19(2):135-41. PubMed ID: 18277134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydroxyethyl starch enhances fibrinolysis in human plasma by diminishing alpha2-antiplasmin-plasmin interactions.
    Nielsen VG
    Blood Coagul Fibrinolysis; 2007 Oct; 18(7):647-56. PubMed ID: 17890952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Additive roles of platelets and fibrinogen in whole-blood fibrin clot formation upon dilution as assessed by thromboelastometry.
    Ninivaggi M; Feijge MA; Baaten CC; Kuiper GJ; Marcus MA; Ten Cate H; Lancé MD; Heemskerk JW; van der Meijden PE
    Thromb Haemost; 2014 Mar; 111(3):447-57. PubMed ID: 24258426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated fibrinogen, von Willebrand factor, and Factor VIII confer resistance to dilutional coagulopathy and activated protein C in normal pregnant women.
    Tanaka KA; Bharadwaj S; Hasan S; Judd M; Abuelkasem E; Henderson RA; Chow JH; Williams B; Mazzeffi MA; Crimmins SD; Malinow AM
    Br J Anaesth; 2019 Jun; 122(6):751-759. PubMed ID: 30916034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rotation thromboelastometry analysis of clot formation and fibrinolysis in severe thrombocytopenia: effect of fibrinogen, activated prothrombin complex concentrate, and thrombin- activatable fibrinolysis inhibitor.
    Shenkman B; Einav Y; Livnat T; Budnik I; Martinowitz U
    Int J Lab Hematol; 2015 Aug; 37(4):521-9. PubMed ID: 25651468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro evaluation of the effect of haemodilution with dextran 40 on coagulation profile as measured by thromboelastometry and multiple electrode aggregometry.
    Kam P; Liou J; Yang K
    Anaesth Intensive Care; 2017 Sep; 45(5):562-568. PubMed ID: 28911285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complete inhibition of fibrinolysis by sustained carboxypeptidase B activity: the role and requirement of plasmin inhibitors.
    Walker JB; Bajzar L
    J Thromb Haemost; 2007 Jun; 5(6):1257-64. PubMed ID: 17389009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haemodilution-induced changes in coagulation and effects of haemostatic components under flow conditions.
    Ogawa S; Ohnishi T; Hosokawa K; Szlam F; Chen EP; Tanaka KA
    Br J Anaesth; 2013 Dec; 111(6):1013-23. PubMed ID: 23794670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of experimental haemodilution on platelet function, thrombin generation and clot firmness: effects of different coagulation factor concentrates.
    Caballo C; Escolar G; Diaz-Ricart M; Lopez-Vílchez I; Lozano M; Cid J; Pino M; Beltrán J; Basora M; Pereira A; Galan AM
    Blood Transfus; 2013 Jul; 11(3):391-9. PubMed ID: 23058866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of haemodilution with succinylated gelatin solution on coagulation in vitro as assessed by thromboelastometry and impedance (multiple electrode) aggregometry.
    Kam P; Varanasi S; Yang KX
    Anaesth Intensive Care; 2018 May; 46(3):272-277. PubMed ID: 29716485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma is the physiologic buffer of tissue plasminogen activator-mediated fibrinolysis: rationale for plasma-first resuscitation after life-threatening hemorrhage.
    Moore HB; Moore EE; Gonzalez E; Wiener G; Chapman MP; Dzieciatkowska M; Sauaia A; Banerjee A; Hansen KC; Silliman C
    J Am Coll Surg; 2015 May; 220(5):872-9. PubMed ID: 25840538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elucidating the molecular mechanisms of fibrinolytic shutdown after severe injury: The role of thrombin-activatable fibrinolysis inhibitor.
    Coleman JR; Moore EE; Kelher MR; Jones K; Cohen MJ; Banerjee A; Silliman CC
    J Trauma Acute Care Surg; 2023 Jun; 94(6):857-862. PubMed ID: 36787438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The in vitro effects of fibrinogen concentrate, factor XIII and fresh frozen plasma on impaired clot formation after 60% dilution.
    Haas T; Fries D; Velik-Salchner C; Reif C; Klingler A; Innerhofer P
    Anesth Analg; 2008 May; 106(5):1360-5, table of contents. PubMed ID: 18420845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of haemodilution with albumin on coagulation in vitro as assessed by rotational thromboelastometry.
    Pathirana S; Wong G; Williams P; Yang K; Kershaw G; Dunkley S; Kam PC
    Anaesth Intensive Care; 2015 Mar; 43(2):187-92. PubMed ID: 25735683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombelastographic whole blood clot formation after ex vivo addition of plasma substitutes: improvements of the induced coagulopathy with fibrinogen concentrate.
    Fenger-Eriksen C; Anker-Møller E; Heslop J; Ingerslev J; Sørensen B
    Br J Anaesth; 2005 Mar; 94(3):324-9. PubMed ID: 15608046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carbon monoxide-releasing molecule-2 decreases fibrinolysis in human plasma.
    Nielsen VG; Kirklin JK; George JF
    Blood Coagul Fibrinolysis; 2009 Sep; 20(6):448-55. PubMed ID: 19581800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.